REFERENCES

1. Lukasova M, Weinberger K, Weiskirchen R, Stremmel W. Onion-skin type of periductular sclerosis in mice with genetic deletion of biliary kindlin-2 as tight junction stabilizer: a pilot experiment indicating a primary sclerosing cholangitis (PSC) phenotype. Metab Target Organ Damage 2024;4:36.

2. Smalheiser NR, Graetz EE, Yu Z, Wang J. Effect size, sample size and power of forced swim test assays in mice: guidelines for investigators to optimize reproducibility. PLoS One 2021;16:e0243668.

3. Juran BD, McCauley BM, Atkinson EJ, et al. Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Hepatol Commun 2024;8:e0496.

4. Hu J, Wu Y, Zhang D, et al. Regulatory T cells-related gene in primary sclerosing cholangitis: evidence from Mendelian randomization and transcriptome data. Genes Immun 2024;Online ahead of print.

5. Mijiti T, Chen X, Ma X, Ma Y, Ma X, Chen B. Inhibition of hepatic PCSK9 as a novel therapeutic target ameliorates metabolic steatohepatitis in mice. Int Immunopharmacol 2024;143:113621.